statistiche ricercatore

MARTIGNONI, EMILIA SILVANA

Distribuzione geografica

Continente	#
NA - Nord America	6.583
EU - Europa	3.631
AS - Asia	1.839
SA - Sud America	163
AF - Africa	80
Continente sconosciuto - Info sul continente non disponibili	21
OC - Oceania	7
Totale	12.324

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.520
IT - Italia	1.776
SG - Singapore	673
UA - Ucraina	618
SE - Svezia	288
VN - Vietnam	283
CN - Cina	267
TR - Turchia	245
HK - Hong Kong	217
FI - Finlandia	193
IE - Irlanda	193
GB - Regno Unito	171
BR - Brasile	138
DE - Germania	125
FR - Francia	101
RU - Federazione Russa	87
NG - Nigeria	68
IN - India	50
BD - Bangladesh	39
CA - Canada	39
BE - Belgio	21
JP - Giappone	17
MX - Messico	11
NL - Olanda	9
AT - Austria	8
ES - Italia	8
AR - Argentina	7
MY - Malesia	7
EU - Europa	6
IQ - Iraq	6
MD - Moldavia	6
ID - Indonesia	5
PL - Polonia	5
SA - Arabia Saudita	5
ZA - Sudafrica	5
BG - Bulgaria	4
CL - Cile	4
NZ - Nuova Zelanda	4
PK - Pakistan	4
AU - Australia	3
CO - Colombia	3
CR - Costa Rica	3
EC - Ecuador	3
IL - Israele	3
LT - Lituania	3
PY - Paraguay	3
TH - Thailandia	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
BB - Barbados	2
DK - Danimarca	2
HN - Honduras	2
HR - Croazia	2
HU - Ungheria	2
JM - Giamaica	2
JO - Giordania	2
KZ - Kazakistan	2
MA - Marocco	2
AZ - Azerbaigian	1
BO - Bolivia	1
BW - Botswana	1
CH - Svizzera	1
CZ - Repubblica Ceca	1
EG - Egitto	1
GL - Groenlandia	1
GR - Grecia	1
GT - Guatemala	1
IM - Isola di Man	1
KG - Kirghizistan	1
KW - Kuwait	1
LB - Libano	1
LK - Sri Lanka	1
LU - Lussemburgo	1
MK - Macedonia	1
NO - Norvegia	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
QA - Qatar	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SV - El Salvador	1
TN - Tunisia	1
TW - Taiwan	1
TZ - Tanzania	1
UZ - Uzbekistan	1
Totale	12.309

Salva come PNG Salva come JPEG

Città	#
Milan	1.302
Fairfield	796
Chandler	587
Jacksonville	463
Woodbridge	442
Ashburn	441
San Jose	379
Seattle	372
Singapore	355
Houston	328
Wilmington	302
Ann Arbor	253
Cambridge	250
Hong Kong	215
Dublin	192
Dallas	171
Chicago	162
Princeton	154
Izmir	145
Nyköping	144
Boardman	104
The Dalles	92
Dong Ket	88
San Mateo	77
Rome	75
Como	70
Abuja	68
Lauterbourg	68
Council Bluffs	67
Beijing	62
Dearborn	60
Hanoi	45
San Diego	44
Ho Chi Minh City	41
Ogden	33
Philadelphia	31
Los Angeles	30
Santa Clara	29
Helsinki	27
New York	27
Norwalk	20
Brussels	19
Düsseldorf	18
Pune	17
São Paulo	17
Munich	14
Tokyo	14
Edinburgh	13
London	12
Turku	12
Atlanta	11
Orem	11
Verona	11
Kunming	9
Nanjing	8
San Francisco	8
Brasília	7
Brooklyn	7
Hefei	7
Miami	7
Nanchang	7
Amsterdam	6
Auburn Hills	6
Chennai	6
Frankfurt am Main	6
Guangzhou	6
Mexico City	6
Montreal	6
Stockholm	6
Toronto	6
Catania	5
Dhaka	5
Kuala Lumpur	5
New Delhi	5
Bari	4
Bologna	4
Chengdu	4
Chongqing	4
Fuzhou	4
Jinan	4
Johannesburg	4
Las Vegas	4
Milton Keynes	4
Nuremberg	4
Rio de Janeiro	4
Shanghai	4
Tianjin	4
Belo Horizonte	3
Bolzano	3
Boston	3
Charlotte	3
Columbus	3
Curitiba	3
Da Nang	3
Fayetteville	3
Fort Worth	3
Hangzhou	3
Hải Dương	3
Kocaeli	3
Madrid	3
Totale	9.005

Salva come PNG Salva come JPEG

Nome	#
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias	247
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease	241
5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms	220
Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.	202
Changes of neuroendocrine axes in patients with menstrual migraine.	194
CARDIOVASCULAR AUTONOMIC MODULATION AND ACTIVITY OF CAROTID BARORECEPTORS AT ALTITUDE.	188
Disordered pupil reactivity in Parkinson's disease.	186
Autonomic regulation of heart rate and peripheral circulation: comparison of high altitude and sea level residents.	185
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.	183
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women.	183
Free plasma catecholamine levels in healthy subjects: a basal and dynamic study.The influence of age.	182
The brain as a target for adrenocortical steroids: cognitive implications.	181
Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants.	181
The association of menstrual migraine with the premenstrual syndrome.	181
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin.	180
Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease.	179
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.	178
Combined response of plasma and platelet catecholamines to different types of short-term stress.	178
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment	175
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.	173
Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.	172
Neuroendocrine changes in luteal function in patients with premenstrual syndrome.	172
High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias.	171
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection.	170
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans.	169
Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study.	169
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.	168
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.	168
Platelet catecholamines in cluster headache.	168
Functional changes of the basal ganglia circuitry in Parkinson's disease.	167
Is seborrhea a sign of autonomic impairment in Parkinson's disease?	167
An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics.	166
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo.	165
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo.	164
Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med. 2000 May-Jun;62(3):386-93.	164
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.	164
Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients.	163
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's disease.	163
The role of language areas in motor control dysfunction in Parkinson's disease.	162
Changes in motoneuron excitability of masseter muscle following exteroceptive stimuli in Parkinson's disease.	162
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection.	160
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study.	160
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.	159
Non-hormonal therapy of premenstrual syndrome.	158
Modifications of local cerebral metabolic rates for glucose and motor behavior in rats with unilateral lesion of the subthalamic nucleus.	158
Sleep attacks in Parkinson's disease: a clinical and polysomnographic study.	157
Parkinson's disease and reproductive life events.	154
Medical healthcare use in Parkinson’s disease: survey in a cohort of ambulatory patients in Italy.	154
LISURIDE PLUS SELEGILINE IN THE TREATMENT OF EARLY PARKINSON'S DISEASE.	153
Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients	153
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease	153
Motor complications of Parkinson's disease.	151
Hashimoto's thyroiditis in association with Tolosa Hunt syndrome: a case report.	150
Premenstrual dysphoric disorder and eating disorders.	149
The influence of gender in the evaluation of platelet and plasma catecholamines.	149
Electrophysiological study on jaw-opening reflex recorded from digastric muscle in Parkinson's disease and primary cranial dystonias.	148
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter,crossover, controlled study.	146
Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000 Sep;62(1):63-88.	145
Active music therapy and Parkinson's disease: methods.	144
Expression polymorphism of the blood-brain barrier component P-glycoprotein(MDR1) in relation to Parkinson's disease.	144
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.	139
CARDIOPRESSOR EFFECTS OF SHORT-TERM TREATMENT WITH CABERGOLINE IN L-DOPA STABLE RESPONDER PARKINSONIAN PATIENTS: RELEVANCE OF POSTPRANDIAL HYPOTENSION.	138
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation.	137
The autonomic nervous system and hypoxia: mountain medicine.	135
ALTITUDE, EXERCISE, AND MOUNTAIN MEDICINE: LESSONS FROM THE FIELD.	134
Autonomic disorders in Parkinson's disease.	133
LISURIDE AND BROMOCRYPTINE IN L-DOPA STABLE-RESPONDER PARKINSONIAN PATIENTS: A COMPARATIVE, DOUBLE-BLIND EVALUATION OF CARDIOPRESSOR AND NEUROCHEMICAL EFFECTS.	131
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease	129
Terguride in stable Parkinson's disease.	124
The effects of physical exercise at high altitude on adrenocortical function in humans.	124
Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.	121
Reproductive life milestones in women with Parkinson's disease.	120
Further characterization of autonomic involvement in multiple system atrophy: a pupillometric study.	116
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial.	116
Parkinson's Disease Comorbidity Study Group. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study.	115
COMT inhibition and safety.	113
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid.	103
Totale	12.324

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	43.273
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	43.273

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	731	0	66	80	112	12	46	28	38	30	116	62	141
2022/2023	1.405	104	89	219	128	93	302	0	172	165	46	59	28
2023/2024	1.987	342	358	334	355	361	88	6	69	47	14	2	11
2024/2025	1.019	2	31	245	31	13	67	11	68	130	61	79	281
2025/2026	2.209	123	100	111	218	287	100	579	71	272	124	103	121
2026/2027	64	45	19	0	0	0	0	0	0	0	0	0	0
Totale													12.324